DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 209150
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
The generic ingredient in THIOTEPA is thiotepa. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the thiotepa profile page.
Summary for 209150
Tradename: | THIOTEPA |
Applicant: | Jiangsu Hengrui Med |
Ingredient: | thiotepa |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 209150
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 209150
Suppliers and Packaging for NDA: 209150
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
THIOTEPA | thiotepa | INJECTABLE;INJECTION | 209150 | ANDA | Sagent Pharmaceuticals | 25021-246 | 25021-246-02 | 1 VIAL in 1 CARTON (25021-246-02) > 1.5 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/VIAL | ||||
Approval Date: | May 4, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription